Please check your internet connection and try again.
# Sompraz HP (Pantoprazole)
## Overview
Sompraz HP is a fixed-dose combination product containing pantoprazole 40 mg, amoxicillin 1000 mg, and clarithromycin 500 mg. Pantoprazole is a proton pump inhibitor (PPI) that reduces gastric acid production. Amoxicillin and clarithromycin are antibiotics used to eradicate *Helicobacter pylori* (H. pylori).
## Primary Indications
* Treatment of *H. pylori* infection in patients with peptic ulcer disease (PUD) or a history of PUD.
## Adult Dosing
* One dose pack should be taken twice daily (morning and evening) for 7 days.
* Each dose pack contains pantoprazole 40 mg, amoxicillin 1000 mg, and clarithromycin 500 mg.
## Pediatric Dosing
* Safety and efficacy in pediatric patients have not been established.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is recommended for pantoprazole, amoxicillin, or clarithromycin in mild to moderate renal impairment. Clarithromycin should be used with caution in severe renal impairment. If necessary, the dose of clarithromycin may need to be reduced.
* **Hepatic Impairment:** No dose adjustment is recommended for pantoprazole in mild to moderate hepatic impairment. Clarithromycin should be used with caution in patients with hepatic impairment.
## Contraindications
* Known hypersensitivity to pantoprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins, cephalosporins, or macrolides.
* Concomitant use of cisapride, pimozide, ergot alkaloids, or lovastatin/simvastatin.
* Severe hepatic impairment (for clarithromycin).
## Adverse Effects
* **Common:** Diarrhea, nausea, abdominal pain, headache, dysgeusia (altered taste), rash.
* **Serious:** *Clostridium difficile*-associated diarrhea (CDAD), severe allergic reactions (anaphylaxis), liver enzyme elevations, QT prolongation (clarithromycin), renal impairment, Stevens-Johnson syndrome/toxic epidermal necrolysis.
* **Amoxicillin-specific:** Oral candidiasis, allergic reactions (including rash, urticaria, angioedema, anaphylaxis), *Clostridium difficile*-associated diarrhea.
* **Clarithromycin-specific:** GI upset, headache, liver dysfunction, QT interval prolongation.
## Key Drug Interactions
* **Pantoprazole:** May decrease the absorption of drugs that require acidic gastric pH (e.g., ketoconazole, itraconazole, some antiretrovirals).
* **Clarithromycin:** Potent inhibitor of CYP3A4. Can increase serum concentrations of drugs metabolized by CYP3A4, including certain statins (lovastatin, simvastatin), anticoagulants (warfarin), antiarrhythmics (digoxin), and CNS depressants. Can also interact with colchicine, increasing colchicine toxicity.
* **Amoxicillin:** May interfere with the effectiveness of oral contraceptives.
## Monitoring
* **During treatment:** Monitor for signs and symptoms of hypersensitivity reactions, diarrhea (especially *C. difficile*), and liver dysfunction.
* **Post-treatment:** *H. pylori* eradication should be confirmed by appropriate diagnostic tests (e.g., stool antigen test, urea breath test) at least 4 weeks after completion of therapy.
## Clinical Pearls
* This combination is a triple therapy regimen for *H. pylori* eradication. Compliance is crucial for successful eradication.
* Patients should be instructed to take the medication as directed for the full course, even if they feel better.
* Advise patients to report any severe diarrhea, rash, or signs of an allergic reaction immediately.
* The need for *H. pylori* retesting should be based on clinical guidelines and patient factors.
***
**Disclaimer:** This information is intended for educational purposes only and does not constitute medical advice. It is essential to consult the most current prescribing information and relevant clinical guidelines for specific patient care decisions.
